Celgene Corporation (CELG) Stock Price

118.15 ▼ -1.23 (-1.03%)
Open: 118.25 Vol: 316.75K Day's range: 117.41 - 119.30 Feb 24, 15:54 EST
Loading chart ...
CELG Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY NEUTRAL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 117.83▲ 117.79▲ 117.74▲ 119.48▼ 116.80▲
MA10 117.73▲ 117.73▲ 118.27▼ 118.53▼ 116.86▲
MA20 117.76▲ 118.27▼ 118.65▼ 117.06▲ 114.18▲
MA50 117.70▲ 118.88▼ 119.17▼ 116.72▲ 108.81▲
MA100 118.31▼ 118.95▼ 117.65▲ 113.34▲ 111.94▲
MA200 118.73▼ 117.45▲ 115.95▲ 109.65▲ 120.11▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.042▲ 0.014▲ -0.117▼ 0.265▲ 0.057▲
RSI 64.942▲ 47.456▼ 43.678▼ 52.940▲ 55.609▲
STOCH 77.494     36.917     18.414▼ 67.107     49.103    
WILL %R 0.000▲ -62.437     -62.437     -52.798     -45.287    
CCI 232.736▲ 10.654     -43.016     22.010     65.551    
Latest Filters Detected On CELG
MA $CELG Price Crossed Below MA(7) Set Alert
CDL $CELG Doji Candlestick Pattern Detected Set Alert
Celgene Corporation News
Sunday, February 26, 2017 08:06 AM
This compound is being developed within a collaboration deal with biotech stalwart Celgene (NASDAQ:CELG). This compound is an anti-cancer stem cell antibody that selectively targets Delta-like ligand 4 (DLL4), an activator of the Notch signaling pathway.
Saturday, February 25, 2017 08:49 AM
Celgene Co. (NASDAQ:CELG) – Investment analysts at Leerink Swann issued their FY2021 EPS estimates for Celgene in a report issued on Tuesday. Leerink Swann analyst G. Porges forecasts that the firm will post earnings per share of $15.43 for the year.
Friday, February 24, 2017 09:04 AM
Celgene's (NASDAQ:CELG) blockbuster blood cancer drug Revlimid was approved by the FDA for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone an autologous stem cell transplant, the first maintenance ...
CELG historical stock data
date open high low close volume
24/02/17 118.25 119.30 117.41 118.15 316,749
23/02/17 119.30 119.38 117.77 119.38 166,649
22/02/17 119.62 120.36 118.91 119.27 221,065
21/02/17 121.55 121.83 119.16 119.51 295,865
17/02/17 118.91 121.09 118.91 121.09 310,816
16/02/17 120.22 120.60 118.26 118.74 225,794
15/02/17 117.10 120.54 117.10 120.36 272,204
14/02/17 116.27 117.12 115.23 116.87 162,503
13/02/17 115.81 116.78 115.81 116.35 107,872
10/02/17 116.59 116.62 115.32 115.59 145,412
Quote Details
Bid:118.11
Ask:118.20
52wk Low:94.47
52wk High:124.78
Vol:316.75K
Avg Vol(3m):4.7M
1Y Chng:+18.04%
1M Chng:+1.04%
Add to Watch List